A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) Used 4 Times Daily in Adults and Children 4 Years of Age or Older With Asthma

Condition:   Asthma Interventions:   Combination Product: Budesonide/albuterol sulfate metered-dose inhaler 80/180 μg;   Combination Product: Budesonide/albuterol sulfate metered-dose inhaler 160/180 μg;   Combination Product: Budesonide metered-dose inhaler 160 µg;   Combination Product: Albuterol sulfate metered-dose inhale r 180 μg;   Combination Product: Placebo metered-dose inhaler Sponsor:   Bond Avillion 2 Development LP Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials